21676281|t|Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
21676281|a|BACKGROUND: Single-volume proton magnetic resonance spectroscopy (1H MRS) has considerable diagnostic potential for Alzheimer's disease (AD). This study investigated 1H MRS in specific regions of the brain, the posterior cingulate gyri (PCG) and the hippocampus, in patients with AD, amnestic mild cognitive impairment (aMCI), and in normal control subjects. METHODS: 1H MRS analysis was carried out on 47 patients with AD, 32 patients with aMCI and 56 normal control subjects (NC group). Volumes of the PCG and hippocampus were assessed, and the metabolic signals of N-acetylaspartate (NAA), choline compounds (Cho), myo-inositol (mI), and creatine (Cr) were quantified. RESULTS: In the PCG, differences between the test groups were found in NAA/Cr, Cho/Cr, mI/Cr and NAA/mI ratios. Group differences were also found in mI/Cr and NAA/mI ratios in the left hippocampus, and in mI/Cr and NAA/mI ratios in the right hippocampus. NAA/Cr ratios increased in the PCG between AD and aMCI patients, and between aMCI and NC patients. Conversely, mI/Cr ratios in the PCG and left hippocampus decreased across AD, aMCI, and NC subjects. In discriminate and ROC (Receiver Operating Characteristic) analyses, a NAA/Cr ratio of <= 1.50 in the PCG indicated optimal potential for discriminating between aMCI patients and normal control subjects. Discriminating potential was also found to be high for a NAA/mI ratio in the PCG of <= 2.72. Despite significant differences between NC and aMCI patients in the mI/Cr ratio in the PCG and in the NAA/mI ratio in the left hippocampus, their sensitivity and specificity were all lower than 75%. CONCLUSION: Proton MRS of the PCG using the NAA/Cr ratio as a metabolic marker indicates considerable potential for distinguishing between aMCI and NC subjects.
21676281	62	82	cognitive impairment	Disease	MESH:D003072
21676281	150	152	1H	Chemical	-
21676281	200	219	Alzheimer's disease	Disease	MESH:D000544
21676281	221	223	AD	Disease	MESH:D000544
21676281	250	252	1H	Chemical	-
21676281	350	358	patients	Species	9606
21676281	364	366	AD	Disease	MESH:D000544
21676281	368	402	amnestic mild cognitive impairment	Disease	MESH:D060825
21676281	404	408	aMCI	Disease	MESH:D060825
21676281	452	454	1H	Chemical	-
21676281	490	498	patients	Species	9606
21676281	504	506	AD	Disease	MESH:D000544
21676281	511	519	patients	Species	9606
21676281	525	529	aMCI	Disease	MESH:D060825
21676281	562	564	NC	Disease	OMIM:617025
21676281	652	669	N-acetylaspartate	Chemical	MESH:C000179
21676281	671	674	NAA	Chemical	MESH:C000179
21676281	677	694	choline compounds	Chemical	-
21676281	696	699	Cho	Chemical	-
21676281	702	714	myo-inositol	Chemical	MESH:D007294
21676281	716	718	mI	Chemical	MESH:D007294
21676281	725	733	creatine	Chemical	MESH:D003401
21676281	735	737	Cr	Chemical	MESH:D003401
21676281	827	830	NAA	Chemical	MESH:C000179
21676281	831	833	Cr	Chemical	MESH:D003401
21676281	835	838	Cho	Chemical	-
21676281	839	841	Cr	Chemical	MESH:D003401
21676281	843	845	mI	Chemical	MESH:D007294
21676281	846	848	Cr	Chemical	MESH:D003401
21676281	853	856	NAA	Chemical	MESH:C000179
21676281	857	859	mI	Chemical	MESH:D007294
21676281	905	907	mI	Chemical	MESH:D007294
21676281	908	910	Cr	Chemical	MESH:D003401
21676281	915	918	NAA	Chemical	MESH:C000179
21676281	919	921	mI	Chemical	MESH:D007294
21676281	961	963	mI	Chemical	MESH:D007294
21676281	964	966	Cr	Chemical	MESH:D003401
21676281	971	974	NAA	Chemical	MESH:C000179
21676281	975	977	mI	Chemical	MESH:D007294
21676281	1011	1014	NAA	Chemical	MESH:C000179
21676281	1015	1017	Cr	Chemical	MESH:D003401
21676281	1054	1056	AD	Disease	MESH:D000544
21676281	1061	1065	aMCI	Disease	MESH:D060825
21676281	1066	1074	patients	Species	9606
21676281	1088	1092	aMCI	Disease	MESH:D060825
21676281	1097	1099	NC	Disease	OMIM:617025
21676281	1100	1108	patients	Species	9606
21676281	1122	1124	mI	Chemical	MESH:D007294
21676281	1125	1127	Cr	Chemical	MESH:D003401
21676281	1184	1186	AD	Disease	MESH:D000544
21676281	1188	1192	aMCI	Disease	MESH:D060825
21676281	1198	1200	NC	Disease	OMIM:617025
21676281	1283	1286	NAA	Chemical	MESH:C000179
21676281	1287	1289	Cr	Chemical	MESH:D003401
21676281	1373	1377	aMCI	Disease	MESH:D060825
21676281	1378	1386	patients	Species	9606
21676281	1473	1476	NAA	Chemical	MESH:C000179
21676281	1477	1479	mI	Chemical	MESH:D007294
21676281	1549	1551	NC	Disease	OMIM:617025
21676281	1556	1560	aMCI	Disease	MESH:D060825
21676281	1561	1569	patients	Species	9606
21676281	1577	1579	mI	Chemical	MESH:D007294
21676281	1580	1582	Cr	Chemical	MESH:D003401
21676281	1611	1614	NAA	Chemical	MESH:C000179
21676281	1615	1617	mI	Chemical	MESH:D007294
21676281	1752	1755	NAA	Chemical	MESH:C000179
21676281	1756	1758	Cr	Chemical	MESH:D003401
21676281	1847	1851	aMCI	Disease	MESH:D060825
21676281	1856	1858	NC	Disease	OMIM:617025
21676281	Positive_Correlation	MESH:C000179	OMIM:617025
21676281	Positive_Correlation	MESH:D003401	MESH:D060825
21676281	Positive_Correlation	MESH:D003401	MESH:D000544
21676281	Positive_Correlation	MESH:C000179	MESH:D060825
21676281	Association	MESH:D007294	MESH:D060825
21676281	Association	MESH:C000179	MESH:D000544
21676281	Negative_Correlation	MESH:D007294	MESH:D000544
21676281	Negative_Correlation	MESH:D003401	OMIM:617025
21676281	Negative_Correlation	MESH:D007294	OMIM:617025

